For Patients with Pain

Options
Bestbird
Bestbird Member Posts: 2,818

Some encouraging news!

Over the past several years there has been increasing pressure on medical professionals to restrict opioid prescriptions, and insurance companies are increasingly denying coverage for these medications. This in turn has caused many people suffering cancer-related pain and other types of chronic pain to be under-treated.

In response to the increasing hesitancy to adequately medicate cancer patients for pain, in 2019 the Center for Disease Control (CDC) issued a letter to three medical societies - the American Society of Hematology, the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network - indicating that people with severe pain from cancer should not be denied insurance coverage for opioid painkillers, and that the previous guidelines for restricting opioid prescriptions weren't intended to deny opioids to patients suffering from chronic pain. From: https://medicalxpress.com/news/2019-04-denials-opioid-coverage-spurs-cdc.html

I'm incorporating the above into my book "The Insider's Guide to Metastatic Breast Cancer," which is available in paperback and eBook formats on Amazon at https://www.amazon.com/Insiders-Guide-Metastatic-Breast-Cancer/dp/179586060X and a complimentary .pdf is available by emailing me at bestbird@hotmail.com

Comments

  • Daniel86
    Daniel86 Member Posts: 271
    edited April 2019

    Without trying to hijack the thread, I would like to invite you guys to try to look into (and eventually ask for) Targin if you dont mind using opiates with the added bonus of lessened SEs. Targin is a newer combo of Oxy and Naloxone. This last drug blocks some of the most bothersome effects of oxy like the high feeling. In Europe they are prescribing it as a first line painkiller for everyday usage and for the recovering time after surgery.

  • Bestbird
    Bestbird Member Posts: 2,818
    edited April 2019

    Danielk86, thank you for your post!  Targin was listed in my Guide in the Pain Management section! "Targiniq ER, which was
    FDA-approved in 2014, is a new opioid that is an extended-release/long-acting
    opioid analgesic to treat pain severe enough to require daily,
    around-the-clock, long-term opioid treatment and for which alternative
    treatment options are inadequate. Targiniq ER has properties that are expected
    to deter, but not totally prevent, abuse of the drug by snorting and injection.
    In addition, the Naloxone in Targiniq ER blocks the euphoric effects of
    oxycodone and helps circumvent the constipation that usually accompanies the
    ingestion of opioids."



  • Daniel86
    Daniel86 Member Posts: 271
    edited April 2019

    Thank YOU for all the effort you put into this cause! Very appreciated indeed

Categories